PATENT CLAIM ANALYSIS

Application Number: 16007853
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["435", "006120"]

Abstract:
Compositions, systems and methods for the diagnosing the risk of acute myocardial infarction are provided. The methods described herein relate to the use of biomarkers, such as gene expression profiles, and analytical tools for providing information to a health care provider or the patient, that is relevant to the cardiovascular health of the patient.

Claim (Index 41):
The method of any one of  claims 32 - 35 , wherein the one or more genes is selected from the group consisting of HBEGF, EDN1, NR4A2, NFKBIA, NR4A3, CCL20, and MGP.

Metadata:
- Claim Count in Document: 75.0
- Percentile: 94.0
- Lexical Diversity: 1.42857
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14714063', '15313493', '14426430', '13913077', '12745220']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6076936457500063
- 35 USC 102 Novelty (BERT): 0.6962439255803886
- Combined Prediction Score: 0.6165486737330446
- Mean Citation Score: 435.4076480000001
- Max Citation Score: 1192.7365
- Similarity Product: 734.5861251755357

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test